10 hours Ago By ABMN Staff
Empowered Funds LLC raised its holdings in shares of Avantor, Inc. ( NYSE:AVTR – Free Report ) by 13.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
The institutional investor owned 12,584 shares of the company’s stock after purchasing an additional 1,451 shares during the period. Empowered Funds LLC’s holdings in Avantor were worth $265,000 at the end of the most recent quarter. Other large investors have also made changes to their positions in the company.
MassMutual Private Wealth & Trust FSB increased its position in shares of Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after purchasing an additional 625 shares in the last quarter.
Nisa Investment Advisors LLC increased its position in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after acquiring an additional 835 shares during the period.
UMB Bank n.a. increased its position in shares of Avantor by 56.
3% in the 4th quarter. UMB Bank n.a.
now owns 2,981 shares of the company’s stock valued at $63,000 after acquiring an additional 1,074 shares during the period. CKW Financial Group increased its position in shares of Avantor by 116.7% in the 4th quarter.
CKW Financial Group now owns 5,200 shares of the company’s stock valued at $110,000 after acquiring an additional 2,800 shares during the period. Finally, First Horizon Advisors Inc. increased its position in shares of Avantor by 30.
8% in the 3rd quarter. First Horizon Advisors Inc. now owns 5,629 shares of the company’s stock valued at $146,000 after acquiring an additional 1,326 shares during the period.
95.08% of the stock is owned by institutional investors and hedge funds. Avantor Price Performance Shares of AVTR opened at $17.
31 on Friday. The business’s 50-day moving average is $20.96 and its two-hundred day moving average is $22.
95. The company has a market capitalization of $11.78 billion, a P/E ratio of 16.
64, a P/E/G ratio of 1.59 and a beta of 1.28.
The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.
07. Avantor, Inc. has a fifty-two week low of $17.
14 and a fifty-two week high of $28.00. Analyst Upgrades and Downgrades Several equities analysts recently issued reports on the company.
Wells Fargo & Company cut their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th.
Raymond James reissued an “outperform” rating and issued a $24.00 target price (down from $26.00) on shares of Avantor in a research report on Monday, February 10th.
Robert W. Baird cut their target price on Avantor from $27.00 to $26.
00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. Stifel Nicolaus cut their target price on Avantor from $28.00 to $26.
00 and set a “buy” rating on the stock in a research report on Monday, February 10th. Finally, Royal Bank of Canada cut their target price on Avantor from $33.00 to $31.
00 and set an “outperform” rating on the stock in a research report on Monday, February 10th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.
com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $25.92. View Our Latest Research Report on Avantor Avantor Company Profile ( Free Report ) Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. See Also Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc.
( NYSE:AVTR – Free Report ). Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter .
.
